Prognostic Significance of Preoperative Bowel Obstruction in Stage III Colorectal Cancer

被引:45
作者
Katoh, Hiroshi [1 ]
Yamashita, Keishi [1 ]
Wang, Guoqin [2 ]
Sato, Takeo [1 ]
Nakamura, Takatoshi [1 ]
Watanabe, Masahiko [1 ]
机构
[1] Kitasato Univ, Sch Med, Dept Surg, Kanagawa, Japan
[2] Kitasato Univ, Sch Med, Kitasato Clin Res Ctr, Dept Community Based Perinatal & Emergency Med, Kanagawa, Japan
关键词
LYMPH-NODE RATIO; LONG-TERM PROGNOSIS; COLON-CANCER; TUMOR-CELLS; CARCINOMA; SURVIVAL; SURGERY; RESECTION; DISTENSION; MARKERS;
D O I
10.1245/s10434-011-1625-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previous studies have suggested a detrimental prognostic effect of preoperative obstruction proximal to colorectal cancer (CRC). If such a detrimental effect is preserved in each stage of advanced (stage II or III) CRC, we can identify high-risk patients. We enrolled 641 patients with pathologically confirmed advanced CRC (stage II, n = 207; stage III, n = 434) who had undergone curative resection of the primary lesion. The association of preoperative obstruction with clinicopathologic parameters was evaluated. Kaplan-Meier analysis and Cox proportional hazard models were used to estimate the effect of preoperative obstruction on disease-free survival in each stage. Preoperative obstruction was seen in 63 patients (9.8%) (stage II, n = 16; stage III, n = 47). Multivariable analysis showed that preoperative obstruction was significantly associated with preoperative elevation of carcinoembryonic antigen level in patients with colon cancer (odds ratio = 3.59; P < 0.001), while it was correlated with poor differentiation in patients with rectal cancer (odds ratio = 3.99; P = 0.016). Preoperative obstruction was a significant prognostic factor in stage III CRC (P < 0.001), but not in stage II disease. Multivariable prognostic analysis showed that preoperative obstruction was a remnant independent prognostic factor in stage III CRC. This finding was confirmed by separate analyses of colon and rectal cancer. Preoperative obstruction was associated with systemic recurrence (P = 0.003) rather than peritoneal or local recurrence. These findings suggest that preoperative obstruction may predict worse long-term prognosis in patients with stage III CRC and may be a potential clinical marker to identify patients with high-risk stage III CRC.
引用
收藏
页码:2432 / 2441
页数:10
相关论文
共 40 条
[11]  
FITCHETT CW, 1986, SURG CLIN N AM, V66, P807
[12]  
GARCIAPECHE P, 1991, HEPATO-GASTROENTEROL, V38, P438
[13]   EFFECT OF LUMINAL DISTENSION ON INTESTINAL TRANS-CAPILLARY FLUID EXCHANGE [J].
GRANGER, DN ;
KVIETYS, PR ;
MORTILLARO, NA ;
TAYLOR, AE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1980, 239 (06) :G516-G523
[14]   Ki-67 and CEA expression as prognostic markers in Dukes' C colorectal cancer [J].
Ishida, H ;
Miwa, H ;
Tatsuta, M ;
Masutani, S ;
Imamura, H ;
Shimizu, J ;
Ezumi, K ;
Kato, H ;
Kawasaki, T ;
Furukawa, H ;
Kawakami, H .
CANCER LETTERS, 2004, 207 (01) :109-115
[15]   Adjuvant chemotherapy for stage III colon cancer - Implications of race/ethnicity, age, and differentiation [J].
Jessup, JM ;
Stewart, A ;
Greene, FL ;
Minsky, BD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (21) :2703-2711
[16]   Primary vs. delayed resection for obstructive left-sided colorectal cancer:: Impact of surgery on patient outcome [J].
Jiang, J. K. ;
Lan, Y. T. ;
Lin, T. C. ;
Chen, W. S. ;
Yang, S. H. ;
Wang, H. S. ;
Chang, S. C. ;
Lin, J. K. .
DISEASES OF THE COLON & RECTUM, 2008, 51 (03) :306-311
[17]   Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer [J].
Johnson, Paul M. ;
Porter, Geoff A. ;
Ricciardi, Rocco ;
Baxter, Nancy N. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (22) :3570-3575
[18]   Prognostic significance of peritoneal tumour cells identified at surgery for colorectal cancer [J].
Katoh, H. ;
Yamashita, K. ;
Sato, T. ;
Ozawa, H. ;
Nakamura, T. ;
Watanabe, M. .
BRITISH JOURNAL OF SURGERY, 2009, 96 (07) :769-777
[19]  
Katoh H, 2008, ANTICANCER RES, V28, P1933
[20]  
Lanza G, 1998, CANCER, V82, P49, DOI 10.1002/(SICI)1097-0142(19980101)82:1<49::AID-CNCR6>3.0.CO